Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens are the main treatment for hirsutism, with individualized care and safe, affordable options needed.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

The document says that common skin conditions in adult women can be treated effectively, with acne being the most common and early-detected melanoma having a high survival rate.

Minoxidil and spironolactone slow hair loss in women.

Two women experienced temporary hair loss and other side effects from imiquimod treatment for cervical issues, which stopped after ending the treatment.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

No cure for female pattern hair loss, but various effective treatments exist.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

The document concludes that more research is needed to create suitable diagnostic criteria and understand PCOS in Korean women, and genetics may allow for personalized treatment.

STK11 gene variations do not predict how well metformin will work for PCOS, but may affect hair loss and excess hair growth.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Pregnancy can cause skin pigmentation, stretch marks, and changes in hair, nails, and sweat glands, with most resolving after birth.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Spironolactone helps regrow hair in women with hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Human enzymes can detoxify harmful substances but might also increase their cancer risk.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Menopause affects hair and skin; more research needed for treatment.